Results 321 to 330 of about 269,737 (365)
Some of the next articles are maybe not open access.
Opioid Therapy and Immunosuppression
American Journal of Therapeutics, 2004The idea that opioids modulate the immune system is not new. By the late 19th century, Cantacuzene, used morphine to suppress cellular immunity and lower the resistance of guinea pigs to bacterial infection. While exogenous opioids mediate immunosuppression, endogenous opiates exert opposite actions.
Oscar A. de Leon-Casasola +2 more
openaire +3 more sources
Dermatologic Therapy With Immunosuppressive Agents
Postgraduate Medicine, 1975The use of powerful immunosuppressive agents such as methotrexate, cyclophosphamide, and azathioprine in the treatment of serious skin diseases is a relatively recent development whose efficacy is borne out in many studies. Using an immunosuppressant often makes possible an appreciable reduction in dosage of steroid necessary to control disease and, in
Robert I. Rudolph, James J. Leyden
openaire +3 more sources
Immunosuppressive drug therapy
Current Opinion in Rheumatology, 1996Intravenous cyclophosphamide therapy for autoimmune disease continues to be the subject of many clinical trials, which in general have strongly supported its use in lupus nephritis but have failed to demonstrate efficacy in severe vasculitis or severe Wegener's granulomatosis.
openaire +2 more sources
Immunosuppressive therapy of autoimmune diseases
Immunology Today, 1993Ciclosporin and cyclophosphamide show a remarkable efficacy in most autoimmune diseases. However, their effect is dependent on continuous drug administration with risks of drug toxicity and over immunosuppression. Results recently obtained in animal models, discussed here by Jean François Bach particularly with anti-CD3 and anti-CD4 monoclonal ...
openaire +4 more sources
Immunosuppressive Therapy in Renal Transplantation
Surgical Clinics of North America, 1971Standard immunosuppressive therapy currently in use is discussed with emphasis upon the mode and site of action. Immunosuppressive therapy is accompanied by many complications, and often it is necessary to modify the dosage for reasons other than rejection. The manner in which this is done at the Cleveland Clinic is described.
Kathryn L. Popowniak, Satoru Nakamoto
openaire +3 more sources
IMMUNOSUPPRESSIVE THERAPY IN WEGENER'S GRANULOMATOSIS
Acta Medica Scandinavica, 1970Abstract. The case history of a 26‐year‐old woman with Wegener's granulomatosis is presented. There were clinical signs of cutaneous, pulmonary, mastoidal and renal involvements. During an oliguric period of five weeks life was maintained by peritoneal dialysis.
Per Teisberg, Erik Enger
openaire +3 more sources
Immunosuppressive therapy for ocular diseases
Current Opinion in Ophthalmology, 2008To identify advances in immunosuppressive therapy of ocular diseases since 2007.The biologics in current use include antitumour necrosis factor-alpha agents (infliximab, etanercept and adalimumab), cytokine receptor antibodies (daclizumab) and interferon-alpha2a. They are effective and comparatively well tolerated options in the treatment of refractory
Aliza Jap, Soon-Phaik Chee
openaire +3 more sources
Transplantation and immunosuppressive therapy
Anaesthesia & Intensive Care Medicine, 2006Abstract Anaesthetist and intensive care physicians will probably be involved, at some stage, in the care of patients who have had or are undergoing organ transplantation. This requires an understanding of the immune response and the drugs used to facilitate transplantation.
David B. Kingsmore, Catherine J Wallace
openaire +2 more sources
Preparing the Patient for Immunosuppressive Therapy
Current Gastroenterology Reports, 2010The decision to start immunosuppressive therapy comes with benefits and risks. Patient selection is as important as medication selection, because some patients are not appropriate for certain therapies. The decision is based on many factors, including diagnosis, level of disease activity, comorbidities, and sometimes socioeconomic status.
openaire +3 more sources
1985
Publisher Summary Immunological tissue damage is a common cause of acute and chronic disease in man. Immune reactions also hinder transplantation of bone marrow or solid organs between histoincompatible individuals. As immunological disease and transplantation reactions often result in severe, occasionally life-threatening conditions, it is important ...
openaire +2 more sources
Publisher Summary Immunological tissue damage is a common cause of acute and chronic disease in man. Immune reactions also hinder transplantation of bone marrow or solid organs between histoincompatible individuals. As immunological disease and transplantation reactions often result in severe, occasionally life-threatening conditions, it is important ...
openaire +2 more sources